UniProt ID | VP37A_HUMAN | |
---|---|---|
UniProt AC | Q8NEZ2 | |
Protein Name | Vacuolar protein sorting-associated protein 37A | |
Gene Name | VPS37A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 397 | |
Subcellular Localization |
Late endosome membrane Peripheral membrane protein. Nucleus. |
|
Protein Description | Component of the ESCRT-I complex, a regulator of vesicular trafficking process. Required for the sorting of endocytic ubiquitinated cargos into multivesicular bodies. May be involved in cell growth and differentiation.. | |
Protein Sequence | MSWLFPLTKSASSSAAGSPGGLTSLQQQKQRLIESLRNSHSSIAEIQKDVEYRLPFTINNLTININILLPPQFPQEKPVISVYPPIRHHLMDKQGVYVTSPLVNNFTMHSDLGKIIQSLLDEFWKNPPVLAPTSTAFPYLYSNPSGMSPYASQGFPFLPPYPPQEANRSITSLSVADTVSSSTTSHTTAKPAAPSFGVLSNLPLPIPTVDASIPTSQNGFGYKMPDVPDAFPELSELSVSQLTDMNEQEEVLLEQFLTLPQLKQIITDKDDLVKSIEELARKNLLLEPSLEAKRQTVLDKYELLTQMKSTFEKKMQRQHELSESCSASALQARLKVAAHEAEEESDNIAEDFLEGKMEIDDFLSSFMEKRTICHCRRAKEEKLQQAIAMHSQFHAPL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSWLFPLTK ------CCCCEECCC | 32.27 | 27251275 | |
8 | Phosphorylation | MSWLFPLTKSASSSA CCCCEECCCCCCCCC | 24.16 | 25690035 | |
10 | Phosphorylation | WLFPLTKSASSSAAG CCEECCCCCCCCCCC | 28.31 | 25159151 | |
12 | Phosphorylation | FPLTKSASSSAAGSP EECCCCCCCCCCCCC | 31.73 | 26657352 | |
13 | Phosphorylation | PLTKSASSSAAGSPG ECCCCCCCCCCCCCC | 24.58 | 25159151 | |
14 | Phosphorylation | LTKSASSSAAGSPGG CCCCCCCCCCCCCCC | 21.46 | 25159151 | |
18 | Phosphorylation | ASSSAAGSPGGLTSL CCCCCCCCCCCHHHH | 18.69 | 25159151 | |
29 (in isoform 3) | Ubiquitination | - | 32.80 | 21906983 | |
29 (in isoform 2) | Ubiquitination | - | 32.80 | 21906983 | |
29 (in isoform 1) | Ubiquitination | - | 32.80 | 21906983 | |
29 | Ubiquitination | LTSLQQQKQRLIESL HHHHHHHHHHHHHHH | 32.80 | 22817900 | |
70 | Ubiquitination | ININILLPPQFPQEK EEEEEECCCCCCCCC | 19.73 | 24816145 | |
100 | Phosphorylation | KQGVYVTSPLVNNFT CCCEEECCCCCCCEE | 13.24 | 25627689 | |
169 | O-linked_Glycosylation | PPQEANRSITSLSVA CCHHHCCCCEEEEHH | 29.99 | 30059200 | |
172 | O-linked_Glycosylation | EANRSITSLSVADTV HHCCCCEEEEHHHCC | 19.58 | 30059200 | |
172 | Phosphorylation | EANRSITSLSVADTV HHCCCCEEEEHHHCC | 19.58 | 30576142 | |
174 | O-linked_Glycosylation | NRSITSLSVADTVSS CCCCEEEEHHHCCCC | 18.28 | 30059200 | |
178 | O-linked_Glycosylation | TSLSVADTVSSSTTS EEEEHHHCCCCCCCC | 16.73 | 30059200 | |
178 | Phosphorylation | TSLSVADTVSSSTTS EEEEHHHCCCCCCCC | 16.73 | 30576142 | |
180 | O-linked_Glycosylation | LSVADTVSSSTTSHT EEHHHCCCCCCCCCC | 22.21 | 30059200 | |
181 | Phosphorylation | SVADTVSSSTTSHTT EHHHCCCCCCCCCCC | 27.63 | 30576142 | |
182 | Phosphorylation | VADTVSSSTTSHTTA HHHCCCCCCCCCCCC | 28.35 | 30576142 | |
182 | O-linked_Glycosylation | VADTVSSSTTSHTTA HHHCCCCCCCCCCCC | 28.35 | 30059200 | |
183 | O-linked_Glycosylation | ADTVSSSTTSHTTAK HHCCCCCCCCCCCCC | 33.98 | 30059200 | |
183 | Phosphorylation | ADTVSSSTTSHTTAK HHCCCCCCCCCCCCC | 33.98 | 30576142 | |
184 | O-linked_Glycosylation | DTVSSSTTSHTTAKP HCCCCCCCCCCCCCC | 22.06 | 30059200 | |
188 | O-linked_Glycosylation | SSTTSHTTAKPAAPS CCCCCCCCCCCCCCC | 27.53 | 30059200 | |
203 | Ubiquitination | FGVLSNLPLPIPTVD CCCCCCCCCCCCCCC | 40.10 | 24816145 | |
215 | O-linked_Glycosylation | TVDASIPTSQNGFGY CCCCCCCCCCCCCCC | 41.07 | 30059200 | |
239 | Ubiquitination | PELSELSVSQLTDMN HHHHHCCHHHHCCCC | 7.08 | 29901268 | |
244 | Ubiquitination | LSVSQLTDMNEQEEV CCHHHHCCCCHHHHH | 46.64 | 29967540 | |
245 | Ubiquitination | SVSQLTDMNEQEEVL CHHHHCCCCHHHHHH | 5.11 | 29901268 | |
257 | Ubiquitination | EVLLEQFLTLPQLKQ HHHHHHHHCHHHHHH | 4.86 | 29967540 | |
268 | Ubiquitination | QLKQIITDKDDLVKS HHHHHHCCHHHHHHH | 41.81 | 24816145 | |
269 | Ubiquitination | LKQIITDKDDLVKSI HHHHHCCHHHHHHHH | 44.48 | 29967540 | |
282 | Ubiquitination | SIEELARKNLLLEPS HHHHHHHCCCCCCCC | 46.47 | 29967540 | |
289 | Phosphorylation | KNLLLEPSLEAKRQT CCCCCCCCHHHHHHH | 29.48 | - | |
293 | Acetylation | LEPSLEAKRQTVLDK CCCCHHHHHHHHHHH | 35.35 | 25953088 | |
293 | Ubiquitination | LEPSLEAKRQTVLDK CCCCHHHHHHHHHHH | 35.35 | 24816145 | |
296 | Phosphorylation | SLEAKRQTVLDKYEL CHHHHHHHHHHHHHH | 27.37 | 29449344 | |
301 | Phosphorylation | RQTVLDKYELLTQMK HHHHHHHHHHHHHHH | 16.10 | 22461510 | |
310 | Ubiquitination | LLTQMKSTFEKKMQR HHHHHHHHHHHHHHH | 30.23 | 29901268 | |
310 | Phosphorylation | LLTQMKSTFEKKMQR HHHHHHHHHHHHHHH | 30.23 | 22461510 | |
329 | Ubiquitination | SESCSASALQARLKV CHHHCHHHHHHHHHH | 11.92 | 29901268 | |
335 | Ubiquitination | SALQARLKVAAHEAE HHHHHHHHHHHHHHH | 25.03 | 29901268 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of VP37A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of VP37A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of VP37A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TS101_HUMAN | TSG101 | physical | 15240819 | |
VPS28_HUMAN | VPS28 | physical | 15240819 | |
A4_HUMAN | APP | physical | 21832049 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
UBAP1_HUMAN | UBAP1 | physical | 24284069 | |
TRI42_HUMAN | TRIM42 | physical | 25416956 | |
UBAP1_HUMAN | UBAP1 | physical | 21757351 | |
TS101_HUMAN | TSG101 | physical | 21757351 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
614898 | Spastic paraplegia 53, autosomal recessive (SPG53) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-18, AND MASSSPECTROMETRY. |